Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.29
-2.3%
$1.34
$0.90
$2.95
$64.51M-0.9844,464 shs25,108 shs
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
$8.30
-1.8%
$6.46
$2.18
$11.12
$89.32M0.9144,889 shs36,485 shs
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$1.46
-2.7%
$2.81
$1.43
$6.30
$54.25M-0.187,406 shs17,319 shs
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
$2.21
-0.5%
$1.73
$1.32
$7.66
$23.28M2.45177,479 shs168,036 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.00%-1.53%-4.09%-15.69%-25.86%
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
0.00%-3.03%+31.04%+186.03%+74.63%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
0.00%-29.13%-48.41%-57.56%-66.97%
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
0.00%-6.36%+20.11%+8.33%-96.48%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.29
-2.3%
$1.34
$0.90
$2.95
$64.51M-0.9844,464 shs25,108 shs
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
$8.30
-1.8%
$6.46
$2.18
$11.12
$89.32M0.9144,889 shs36,485 shs
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$1.46
-2.7%
$2.81
$1.43
$6.30
$54.25M-0.187,406 shs17,319 shs
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
$2.21
-0.5%
$1.73
$1.32
$7.66
$23.28M2.45177,479 shs168,036 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.00%-1.53%-4.09%-15.69%-25.86%
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
0.00%-3.03%+31.04%+186.03%+74.63%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
0.00%-29.13%-48.41%-57.56%-66.97%
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
0.00%-6.36%+20.11%+8.33%-96.48%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.00
N/AN/AN/A
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
0.00
N/AN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
4.00
Strong BuyN/AN/A
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.32M48.87N/AN/A$0.48 per share2.69
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
$523.28M0.17N/AN/A$7.39 per share1.12
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$4.01M13.53N/AN/A($0.07) per share-20.86
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
$620K37.57N/AN/A$4.30 per share0.51
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agape ATP Corporation stock logo
ATPC
Agape ATP
-$2.47M-$0.41N/AN/A-183.13%-20.32%-18.55%11/12/2025 (Estimated)
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
-$47.49M-$1.89N/AN/A-45.41%-38.33%-25.34%9/11/2025 (Estimated)
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
-$15.36MN/A0.00N/AN/AN/AN/AN/AN/A
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
-$8.71M-$3.86N/AN/A-2,757.86%-85.01%-78.08%N/A

Latest MGRX, BNR, EUDA, and ATPC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
N/A-$0.57N/A-$0.57N/A$0.17 million
8/13/2025Q2 2025
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A-$0.01N/A-$0.01N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/AN/AN/AN/AN/A
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/AN/AN/AN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/AN/AN/AN/AN/A
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A
20.36
20.33
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/A
3.02
2.76
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/A
0.18
0.15
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
N/A
0.07
0.07

Institutional Ownership

CompanyInstitutional Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.01%
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
30.03%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
4.35%
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
56.72%

Insider Ownership

CompanyInsider Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
9.67%
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
30.30%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/A
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
16.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agape ATP Corporation stock logo
ATPC
Agape ATP
4050.01 million45.17 millionNot Optionable
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
1,39010.76 million7.50 millionNot Optionable
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
237.16 millionN/ANot Optionable
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
310.54 million8.85 millionNot Optionable

Recent News About These Companies

Mangoceuticals, Inc. (NASDAQ:MGRX) Short Interest Down 54.2% in August
Mangoceuticals President Tony Isaac Resigns
Mangoceuticals Acquires IP to Expand Product Line

New MarketBeat Followers Over Time

Media Sentiment Over Time

Agape ATP stock logo

Agape ATP NASDAQ:ATPC

$1.29 -0.03 (-2.27%)
Closing price 09/5/2025 03:40 PM Eastern
Extended Trading
$1.29 0.00 (0.00%)
As of 09/5/2025 04:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Burning Rock Biotech stock logo

Burning Rock Biotech NASDAQ:BNR

$8.30 -0.16 (-1.83%)
Closing price 09/5/2025 03:58 PM Eastern
Extended Trading
$8.50 +0.21 (+2.47%)
As of 09/5/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. In addition, the company provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients. Further, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. Additionally, the company offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited was incorporated in 2014 and is headquartered in Guangzhou, China.

EUDA Health stock logo

EUDA Health NASDAQ:EUDA

$1.46 -0.04 (-2.67%)
Closing price 09/5/2025 03:56 PM Eastern
Extended Trading
$1.47 +0.01 (+0.68%)
As of 09/5/2025 06:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.

Mangoceuticals stock logo

Mangoceuticals NASDAQ:MGRX

$2.21 -0.01 (-0.45%)
Closing price 09/5/2025 04:00 PM Eastern
Extended Trading
$2.12 -0.09 (-3.85%)
As of 09/5/2025 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.